This study characterizes the tumor-suppressing effects of let-7a and miR-26a in malignant melanoma and identifies, for the first time, microphthalmia-associated transcription factor (MITF) as a novel gene target of miR-26a in malignant melanoma. This evidence concerns the gene MITF and neoplasm.